Cargando…

Can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin?

Detalles Bibliográficos
Autores principales:	Dutta, Noton K., Karakousis, Petros C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604300/ https://www.ncbi.nlm.nih.gov/pubmed/26528265 http://dx.doi.org/10.3389/fmicb.2015.01117

Ejemplares similares

Targeting the Mycobacterium tuberculosis Stringent Response as a Strategy for Shortening Tuberculosis Treatment
por: Danchik, Carina, et al.
Publicado: (2021)

High-dose rifampicin kills persisters, shortens treatment duration, and reduces relapse rate in vitro and in vivo
por: Hu, Yanmin, et al.
Publicado: (2015)

Transcriptional Approach for Decoding the Mechanism of rpoC Compensatory Mutations for the Fitness Cost in Rifampicin-Resistant Mycobacterium tuberculosis
por: Xu, Zhihong, et al.
Publicado: (2018)

The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis
por: Svensson, Elin M, et al.
Publicado: (2018)

Systems Biology-Based Identification of Mycobacterium tuberculosis Persistence Genes in Mouse Lungs
por: Dutta, Noton K., et al.
Publicado: (2014)

Commentary: Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates
por: Sharma, Sandeep, et al.
Publicado: (2017)

Gene Enrichment Analysis Reveals Major Regulators of Mycobacterium tuberculosis Gene Expression in Two Models of Antibiotic Tolerance
por: Matern, William M., et al.
Publicado: (2018)

Fluoromycobacteriophages Can Detect Viable Mycobacterium tuberculosis and Determine Phenotypic Rifampicin Resistance in 3–5 Days From Sputum Collection
por: Rondón, Liliana, et al.
Publicado: (2018)

Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice
por: Chuang, Yu-Min, et al.
Publicado: (2018)

Can nirmatrelvir/ritonavir treatment shorten the duration of COVID-19 isolation?
por: Kim, Haein, et al.
Publicado: (2022)

Altered Mycobacterium tuberculosis Cell Wall Metabolism and Physiology Associated With RpoB Mutation H526D
por: Campodónico, Victoria L., et al.
Publicado: (2018)

Host-pathogen relationship in retreated tuberculosis with major rifampicin resistance–conferring mutations
por: Hang, Nguyen Thi Le, et al.
Publicado: (2023)

Analysis of Combination Drug Therapy to Develop Regimens with Shortened Duration of Treatment for Tuberculosis
por: Drusano, George L., et al.
Publicado: (2014)

Pyogenic Arthritis of the Fingers and the Wrist: Can We Shorten Antimicrobial Treatment Duration?
por: Meier, Rahel, et al.
Publicado: (2017)

On Shortening the Duration of Labour
por: Gray, J.
Publicado: (1858)

The anti-tubercular activity of simvastatin is mediated by cholesterol-driven autophagy via the AMPK-mTORC1-TFEB axis
por: Bruiners, Natalie, et al.
Publicado: (2020)

A Glutamine Insertion at Codon 432 of RpoB Confers Rifampicin Resistance in Mycobacterium tuberculosis
por: Lai, Li-Yin, et al.
Publicado: (2020)

Dihydroartemisinin-Loaded Chitosan Nanoparticles Inhibit the Rifampicin-Resistant Mycobacterium tuberculosis by Disrupting the Cell Wall
por: Gu, Xiujuan, et al.
Publicado: (2021)

Tedizolid-Rifampicin Combination Prevents Rifampicin-Resistance on in vitro Model of Staphylococcus aureus Mature Biofilm
por: Gidari, Anna, et al.
Publicado: (2020)

A Decision Tree for Rapid Quality Assurance and Control of Rifampicin-Containing Oral Dosage Forms for Global Distribution for Tuberculosis Treatment
por: Ashokraj, Y., et al.
Publicado: (2008)

Antibiotic Treatment Shapes the Antigenic Environment During Chronic TB Infection, Offering Novel Targets for Therapeutic Vaccination
por: Chuang, Yu-Min, et al.
Publicado: (2020)

Editorial: Alternative Therapeutics Against Antimicrobial-Resistant Pathogens
por: Thombre, Rebecca, et al.
Publicado: (2019)

Hypoxic Non-replicating Persistent Mycobacterium tuberculosis Develops Thickened Outer Layer That Helps in Restricting Rifampicin Entry
por: Jakkala, Kishor, et al.
Publicado: (2019)

Multiplex LNA probe-based RAP assay for rapid and highly sensitive detection of rifampicin-resistant Mycobacterium tuberculosis
por: Zhang, Ruiqing, et al.
Publicado: (2023)

Whole-Genome Sequencing to Identify Missed Rifampicin and Isoniazid Resistance Among Tuberculosis Isolates—Chennai, India, 2013–2016
por: Tamilzhalagan, Sembulingam, et al.
Publicado: (2021)

Effects of second-line anti-tuberculosis drugs on the intestinal microbiota of patients with rifampicin-resistant tuberculosis
por: Wu, Chunli, et al.
Publicado: (2023)

Can diabetes mellitus modify the plasma concentrations of rifampicin in patients under treatment for tuberculosis?
por: Fonseca, Adriana Aparecida Durães, et al.
Publicado: (2020)

Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
por: Zhang, Zehua, et al.
Publicado: (2014)

Sterol 27-hydroxylase gene dosage and the antiatherosclerotic effect of Rifampicin in mice
por: Zurkinden, Line, et al.
Publicado: (2018)

Higher Serum Cholesterol Levels Are Associated With Reduced Systemic Inflammation and Mortality During Tuberculosis Treatment Independent of Body Mass Index
por: Chidambaram, Vignesh, et al.
Publicado: (2021)

Are There Sex-Specific Differences in Response to Adjunctive Host-Directed Therapies for Tuberculosis?
por: Dutta, Noton K., et al.
Publicado: (2020)

Mechanisms of Antibiotic Tolerance in Mycobacterium avium Complex: Lessons From Related Mycobacteria
por: Parker, Harley, et al.
Publicado: (2020)

Shortening Tuberculosis treatment schedules in children
por: Barnes, Katharine
Publicado: (2022)

Airway microecology in rifampicin-resistant and rifampicin-sensitive pulmonary tuberculosis patients
por: Cai, Xingshan, et al.
Publicado: (2022)

Pattern of methane levels with lactulose breath testing; can we shorten the test duration?
por: Shaker, Anisa, et al.
Publicado: (2021)

Orthodontic treatment time: can it be shortened?
por: Moresca, Ricardo
Publicado: (2018)

Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?
por: Schmaltz, Carolina Arana Stanis, et al.
Publicado: (2019)

A Lower Dose of Efavirenz Can Be Coadministered With Rifampicin and Isoniazid in Tuberculosis Patients
por: Kaboggoza, Julian P, et al.
Publicado: (2019)

Synergistic Response of Rifampicin with Hydroperoxides on Mycobacterium: A Mechanistic Study
por: Patel, Yesha S., et al.
Publicado: (2017)

The Synergistic Effect of Exogenous Glutamine and Rifampicin Against Mycobacterium Persisters
por: Huang, Xue, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vs80rre4d5g4rcsvhuqoq7gngm